ZA915372B - Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereof - Google Patents
Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereofInfo
- Publication number
- ZA915372B ZA915372B ZA915372A ZA915372A ZA915372B ZA 915372 B ZA915372 B ZA 915372B ZA 915372 A ZA915372 A ZA 915372A ZA 915372 A ZA915372 A ZA 915372A ZA 915372 B ZA915372 B ZA 915372B
- Authority
- ZA
- South Africa
- Prior art keywords
- pyrazolidinone
- cck
- pharmaceutical formulations
- gastrin antagonists
- gastrin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D231/08—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55348990A | 1990-07-17 | 1990-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA915372B true ZA915372B (en) | 1993-03-31 |
Family
ID=24209587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA915372A ZA915372B (en) | 1990-07-17 | 1991-07-10 | Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereof |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0467614A1 (no) |
| JP (1) | JPH04230367A (no) |
| KR (1) | KR960005950B1 (no) |
| CN (1) | CN1032000C (no) |
| AU (2) | AU644190B2 (no) |
| BR (1) | BR9103042A (no) |
| CA (1) | CA2046672A1 (no) |
| CS (1) | CS219391A3 (no) |
| FI (1) | FI913431A (no) |
| HU (1) | HUT58296A (no) |
| IE (1) | IE912489A1 (no) |
| IL (1) | IL98785A (no) |
| MX (1) | MX9100164A (no) |
| NO (1) | NO912772L (no) |
| NZ (1) | NZ238912A (no) |
| PT (1) | PT98323A (no) |
| RU (1) | RU2076100C1 (no) |
| YU (1) | YU124391A (no) |
| ZA (1) | ZA915372B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5191084A (en) * | 1991-05-01 | 1993-03-02 | American Home Products Corporation | Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents |
| US5153191A (en) * | 1991-08-20 | 1992-10-06 | Warner-Lambert Company | Cholecystokinin antagonists useful for treating depression |
| US5399708A (en) * | 1993-11-12 | 1995-03-21 | Eli Lilly And Company | Pyrazolidin-3-one derivatives |
| GB0011095D0 (en) * | 2000-05-08 | 2000-06-28 | Black James Foundation | astrin and cholecystokinin receptor ligands (III) |
| PE20020856A1 (es) * | 2001-02-13 | 2002-11-11 | Aventis Pharma Gmbh | 1,2,3,4-tetrahidronaftil aminas aciladas |
| UA79804C2 (en) * | 2002-07-03 | 2007-07-25 | Janssen Pharmaceutica Nv | Cck-1 receptor modulators |
| GB0312368D0 (en) * | 2003-05-30 | 2003-07-02 | Univ Aston | Novel ureido- and amido-pyrazolone derivatives |
| US8410135B2 (en) * | 2007-06-15 | 2013-04-02 | Solvay Pharmaceuticals B.V. | 4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE530886A (no) * | 1953-08-03 | |||
| FR82186E (fr) * | 1959-04-10 | 1964-01-04 | Kodak Pathe | Nouveau produit photographique et procédé pour le traitement de ce produit |
| FR2529786A1 (fr) * | 1982-07-12 | 1984-01-13 | Nativelle Sa Ets | Compositions pharmaceutiques a base de derives de la pyrazolone-5, nouveaux produits et procede de preparation |
| DE3407506A1 (de) * | 1984-03-01 | 1985-09-05 | A. Nattermann & Cie GmbH, 5000 Köln | 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoline, verfahren zu ihrer herstellung und deren verwendung |
| EP0166355A2 (en) * | 1984-06-26 | 1986-01-02 | Merck & Co. Inc. | Substituted aminophenyl compounds and acylaminophenyl compounds and pharmaceutical compositions containing them |
| US5089622A (en) * | 1988-12-12 | 1992-02-18 | Mitsui Toatsu Chemicals Incorporated | (-)-2-pyrazoline compounds and therapeutic agent for cerebrovascular disorders containing the same as effective ingredient |
| US5191084A (en) * | 1991-05-01 | 1993-03-02 | American Home Products Corporation | Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents |
-
1991
- 1991-07-10 NZ NZ238912A patent/NZ238912A/en unknown
- 1991-07-10 CA CA002046672A patent/CA2046672A1/en not_active Abandoned
- 1991-07-10 IL IL9878591A patent/IL98785A/en not_active IP Right Cessation
- 1991-07-10 ZA ZA915372A patent/ZA915372B/xx unknown
- 1991-07-11 MX MX9100164A patent/MX9100164A/es unknown
- 1991-07-12 AU AU80409/91A patent/AU644190B2/en not_active Ceased
- 1991-07-15 HU HU912376A patent/HUT58296A/hu unknown
- 1991-07-15 CS CS912193A patent/CS219391A3/cs unknown
- 1991-07-15 PT PT98323A patent/PT98323A/pt not_active Application Discontinuation
- 1991-07-15 NO NO91912772A patent/NO912772L/no unknown
- 1991-07-15 KR KR1019910012030A patent/KR960005950B1/ko active IP Right Grant
- 1991-07-15 EP EP91306374A patent/EP0467614A1/en not_active Ceased
- 1991-07-16 FI FI913431A patent/FI913431A/fi not_active Application Discontinuation
- 1991-07-16 CN CN91104911A patent/CN1032000C/zh not_active Expired - Fee Related
- 1991-07-16 BR BR919103042A patent/BR9103042A/pt not_active Application Discontinuation
- 1991-07-16 YU YU124391A patent/YU124391A/sh unknown
- 1991-07-16 JP JP3175054A patent/JPH04230367A/ja not_active Withdrawn
- 1991-07-16 RU SU915001032A patent/RU2076100C1/ru active
- 1991-07-16 IE IE248991A patent/IE912489A1/en unknown
-
1994
- 1994-02-21 AU AU55293/94A patent/AU5529394A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX9100164A (es) | 1992-02-28 |
| YU124391A (sh) | 1994-01-20 |
| AU8040991A (en) | 1992-01-23 |
| IL98785A0 (en) | 1992-07-15 |
| JPH04230367A (ja) | 1992-08-19 |
| IE912489A1 (en) | 1992-01-29 |
| PT98323A (pt) | 1992-06-30 |
| KR960005950B1 (ko) | 1996-05-06 |
| AU5529394A (en) | 1994-04-28 |
| EP0467614A1 (en) | 1992-01-22 |
| RU2076100C1 (ru) | 1997-03-27 |
| IL98785A (en) | 1995-11-27 |
| CA2046672A1 (en) | 1992-01-18 |
| CN1032000C (zh) | 1996-06-12 |
| AU644190B2 (en) | 1993-12-02 |
| CN1058209A (zh) | 1992-01-29 |
| FI913431A0 (fi) | 1991-07-16 |
| NO912772D0 (no) | 1991-07-15 |
| NZ238912A (en) | 1992-12-23 |
| CS219391A3 (en) | 1992-02-19 |
| FI913431A (fi) | 1992-01-18 |
| KR920002548A (ko) | 1992-02-28 |
| HUT58296A (en) | 1992-02-28 |
| BR9103042A (pt) | 1992-04-28 |
| NO912772L (no) | 1992-01-20 |
| HU912376D0 (en) | 1991-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL99246A0 (en) | Angiotensin ii receptor antagonists and pharmaceutical compositions containing them | |
| CS375691A3 (en) | Pharmaceutical agents | |
| ZA954315B (en) | Gastrin and cck antagonists | |
| HUP9901092A3 (en) | Benzimidazole compounds and their pharmaceutical use | |
| IL99957A0 (en) | Piperidinylcamphorsulfonyl oxytocin antagonists and pharmaceutical compositions containing them | |
| EP0498268A3 (en) | 5-oxo-l-proline derivatives and pharmaceutical use thereof | |
| ZA917149B (en) | 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof | |
| IL97122A0 (en) | Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them | |
| GB9217475D0 (en) | Nauroprotective use cck antagonists | |
| EP0437216A3 (en) | Silicone-dissolving and solubilizing agents | |
| IL98785A0 (en) | Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereof | |
| ZA911065B (en) | Chemical and pharmaceutical compositions | |
| AP9000236A0 (en) | Pharmaceutical formulations | |
| GB9000241D0 (en) | Pharmaceutical use | |
| HU9203050D0 (en) | Thieno-cyclopentanole-oximes and pharmaceutical preparatives containing them | |
| GB9502503D0 (en) | Gastrin and CCK antagonists | |
| GB9027014D0 (en) | Pharmaceutical agents | |
| GB9115107D0 (en) | Pharmaceutical agents | |
| IL107368A0 (en) | Inositol derivatives and their pharmaceutical use | |
| GB9113622D0 (en) | Medicinal agents | |
| ZA915026B (en) | Pharmaceutical formulations | |
| GB9023656D0 (en) | New pharmaceutical use | |
| GB9004372D0 (en) | New pharmaceutical use | |
| GB9021241D0 (en) | New pharmaceutical use | |
| GB9014230D0 (en) | New pharmaceutical use |